TY - JOUR T1 - The impact of different antibiotic treatment regimens on mortality in <em>Mycobacterium avium</em> complex pulmonary disease: a population-based cohort study JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.01875-2019 VL - 56 IS - 3 SP - 1901875 AU - Sarah K. Brode AU - Hannah Chung AU - Michael A. Campitelli AU - Jeffrey C. Kwong AU - Rinku Sutradhar AU - Alex Marchand-Austin AU - Kevin L. Winthrop AU - Frances B. Jamieson AU - Theodore K. Marras Y1 - 2020/09/01 UR - http://erj.ersjournals.com/content/56/3/1901875.abstract N2 - Evidence-based guidelines recommend the combination of macrolide–ethambutol–rifamycin as first-line treatment for Mycobacterium avium complex pulmonary disease (MAC-PD) [1]. Whether this regimen results in improved survival is unknown.No significant difference in mortality among patients treated with different antibiotic regimens for Mycobacterium avium pulmonary disease https://bit.ly/3abXjDJWe thank IMS Brogan Inc. for use of their Drug Information Database. ER -